OSCR

Betaine Attenuates Hyperhomocysteinemia-Induced Cognitive Impairment by Suppressing Oxidative Stress and Activating the PI3K/AKT/GSK-3β Pathway.

Overview

Authors: Xiaolong Gu1,2, Yuan Fu1,2, Yongli Zhao1,2, Zhenyi Liu3, Yixiao Yang1,2, Qi Xie1,2, Peng Ma1,2, Zhiwei Peng1,2, Zhizhen Liu1,2, Jianting Li1,2, Jun Xie1,2
  1. Shanxi Key Laboratory of Birth Defect and Cell Regeneration, Department of Biochemistry and Molecular Biology, Shanxi Medical University, Taiyuan 030001, China; (X.G.); (Y.F.); (Y.Z.); (Y.Y.); (Q.X.); (P.M.); (Z.P.); (Z.L.)
  2. Key Laboratory of Coal Environmental Pathogenicity and Prevention, Ministry of Education, Shanxi Medical University, Taiyuan 030001, China
  3. School of Pharmaceutical Science, Shanxi Medical University, Taiyuan 030001, China
Institutions: Shanxi Medical University (China)
Journal: Antioxidants (Basel, Switzerland), volume 15, issue 7, article 807
Dates: received 30 March 2026; accepted 26 June 2026; published online 27 June 2026
Type: Research article · Language: English
License: CC BY
Identifiers: DOI 10.3390/antiox15070807 · PMID 42510538 · PMCID PMC13405995 · OpenAlex W7166665513
Open access: gold, a free copy (OpenAlex)
Categories: mouse (organism), Alzheimer's / dementia (population), cellular / molecular (subfield)
Methods: Statistics, Smoothing, state filtering, decompositions, Machine learning
Keywords: betaine, homocysteine, ROS, cognitive impairment, PI3K/AKT/GSK-3β pathway
Topic: Folate and B Vitamins Research (Nutrition and Dietetics, Nursing), according to OpenAlex
Funding: National Natural Science Foundation of China (82201841, U23A20420); Shanxi Basic Research Program (202203021212369, 202403021221156); Shanxi Medical University (XD2114); Shanxi Province Higher Education "Billion Project" Science and Technology Guidance Project
Citations: not cited yet (Europe PMC); 60 references in the paper

Abstract

High homocysteine levels are a key risk factor for cognitive impairment, a major public health concern in aging societies. Although betaine is known to reduce Hcy levels, its effects on hyperhomocysteinemia (hHcy)-induced cognitive impairment and the underlying mechanisms remain unclear. Here, we established an hHcy-induced cognitive impairment mouse model by feeding mice a high-methionine diet for 8 weeks, followed by betaine supplementation for 14 days. Betaine treatment attenuated hHcy-induced cognitive impairment. This improvement was accompanied by alleviation of neuropathological alterations and enhancement of antioxidant capacity. Notably, betaine suppressed reactive oxygen species (ROS) accumulation, neuronal apoptosis, and Tau hyperphosphorylation at Ser396 and Thr231 in both mouse hippocampus and HT-22 cells. Mechanistically, betaine-induced activation of the PI3K/AKT/GSK-3β pathway was effectively blocked by the PI3K inhibitor LY294002. Notably, treatment with the ROS scavenger N-acetylcysteine (NAC) alone phenocopied this activation, suggesting that ROS functions as an upstream regulator of this signaling cascade. Collectively, our data demonstrate that betaine attenuates hHcy-induced cognitive impairment by suppressing oxidative stress-driven apoptosis and Tau pathology through modulation of the PI3K/AKT/GSK-3β signaling pathway. These findings suggest that betaine may hold promise for further preclinical and clinical studies, although long-term efficacy and safety evaluations remain necessary.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper links to its data and to no code of its authors: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

Data Availability Statement

The RNA-seq data for this article are available in the GEO database under accession number GSE308639 at https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE308639, accessed on 25 June 2026.

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 27 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 11 authors, 5 keywords, 4 funders, 60 references.

Cite

This paper

Gu, X., Fu, Y., Zhao, Y., Liu, Z., Yang, Y., Xie, Q., Ma, P., Peng, Z., Liu, Z., Li, J., & Xie, J. (2026). Betaine Attenuates Hyperhomocysteinemia-Induced Cognitive Impairment by Suppressing Oxidative Stress and Activating the PI3K/AKT/GSK-3β Pathway. Antioxidants (Basel, Switzerland), 15(7), 807. https://doi.org/10.3390/antiox15070807

BibTeX

@article{gu2026betaine,
author = {Gu, Xiaolong and Fu, Yuan and Zhao, Yongli and Liu, Zhenyi and Yang, Yixiao and Xie, Qi and Ma, Peng and Peng, Zhiwei and Liu, Zhizhen and Li, Jianting and Xie, Jun},
title = {{Betaine Attenuates Hyperhomocysteinemia-Induced Cognitive Impairment by Suppressing Oxidative Stress and Activating the PI3K/AKT/GSK-3β Pathway}},
journal = {Antioxidants (Basel, Switzerland)},
year = {2026},
month = jun,
volume = {15},
number = {7},
pages = {807},
publisher = {Multidisciplinary Digital Publishing Institute (MDPI)},
issn = {2076-3921},
doi = {10.3390/antiox15070807},
url = {https://doi.org/10.3390/antiox15070807},
pmid = {42510538},
pmcid = {PMC13405995}
}

RIS

TY - JOUR
AU - Gu, Xiaolong
AU - Fu, Yuan
AU - Zhao, Yongli
AU - Liu, Zhenyi
AU - Yang, Yixiao
AU - Xie, Qi
AU - Ma, Peng
AU - Peng, Zhiwei
AU - Liu, Zhizhen
AU - Li, Jianting
AU - Xie, Jun
TI - Betaine Attenuates Hyperhomocysteinemia-Induced Cognitive Impairment by Suppressing Oxidative Stress and Activating the PI3K/AKT/GSK-3β Pathway
T2 - Antioxidants (Basel, Switzerland)
J2 - Antioxidants (Basel)
PY - 2026
DA - 2026/06/27
VL - 15
IS - 7
SP - 807
SN - 2076-3921
PB - Multidisciplinary Digital Publishing Institute (MDPI)
DO - 10.3390/antiox15070807
UR - https://doi.org/10.3390/antiox15070807
LA - en
ER -

CSL-JSON

{
"id": "10.3390/antiox15070807",
"type": "article-journal",
"title": "Betaine Attenuates Hyperhomocysteinemia-Induced Cognitive Impairment by Suppressing Oxidative Stress and Activating the PI3K/AKT/GSK-3β Pathway",
"container-title": "Antioxidants (Basel, Switzerland)",
"author": [
{
"family": "Gu",
"given": "Xiaolong"
},
{
"family": "Fu",
"given": "Yuan"
},
{
"family": "Zhao",
"given": "Yongli"
},
{
"family": "Liu",
"given": "Zhenyi"
},
{
"family": "Yang",
"given": "Yixiao"
},
{
"family": "Xie",
"given": "Qi"
},
{
"family": "Ma",
"given": "Peng"
},
{
"family": "Peng",
"given": "Zhiwei"
},
{
"family": "Liu",
"given": "Zhizhen"
},
{
"family": "Li",
"given": "Jianting"
},
{
"family": "Xie",
"given": "Jun"
}
],
"container-title-short": "Antioxidants (Basel)",
"volume": "15",
"issue": "7",
"page": "807",
"DOI": "10.3390/antiox15070807",
"PMID": "42510538",
"PMCID": "PMC13405995",
"ISSN": "2076-3921",
"publisher": "Multidisciplinary Digital Publishing Institute (MDPI)",
"URL": "https://doi.org/10.3390/antiox15070807",
"language": "en",
"issued": {
"date-parts": [
[
2026,
6,
27
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.3390/biology15161423
Circulating Homocysteine and Choroid Plexus Volume Across the Alzheimer's Disease Continuum: Cross-Sectional and Progression-Related Associations.
Journal: Biology
In common: Alzheimer's / dementia, 4 references
[2] doi:10.1186/s13195-023-01311-9
Identification of methylation-regulated genes modulating microglial phagocytosis in hyperhomocysteinemia-exacerbated Alzheimer's disease.
Journal: Alzheimer's research & therapy
In common: Alzheimer's / dementia, mouse, cellular / molecular, 3 references
[3] doi:10.1038/s41419-024-07179-3 [code]
Enhancing mitochondrial one-carbon metabolism is neuroprotective in Alzheimer's disease models.
Journal: Cell death & disease
In common: Alzheimer's / dementia, cellular / molecular, 2 references
[4] doi:10.1186/s12964-023-01288-w
Defective quality control autophagy in Hyperhomocysteinemia promotes ER stress and consequent neuronal apoptosis through proteotoxicity.
Journal: Cell communication and signaling : CCS
In common: cellular / molecular, 3 references
[5] doi:10.7554/elife.93094
7,8-Dihydroxyflavone is a direct inhibitor of human and murine pyridoxal phosphatase.
Journal: eLife
In common: mouse, cellular / molecular, 2 references
[6] doi:10.1038/s41531-023-00531-y
Targeted metabolomic analysis in Parkinson's disease brain frontal cortex and putamen with relation to cognitive impairment.
Journal: NPJ Parkinson's disease
In common: Alzheimer's / dementia, 2 references
[7] doi:10.1038/s44318-024-00165-7
Structural insights into the molecular effects of the anthelmintics monepantel and betaine on the Caenorhabditis elegans acetylcholine receptor ACR-23.
Journal: The EMBO journal
In common: cellular / molecular, 2 references
[8] doi:10.1186/s11658-025-00772-0
Integrated transcriptomics and metabolomics confirms the oxidative stress mechanism of hypothermia-induced neuronal necroptosis.
Journal: Cellular & molecular biology letters
In common: mouse, cellular / molecular, 3 references
[9] doi:10.1186/s13071-024-06278-6
Identification and coregulation pattern analysis of long noncoding RNAs in the mouse brain after Angiostrongylus cantonensis infection.
Journal: Parasites & vectors
In common: mouse, cellular / molecular, 3 references
[10] doi:10.1186/s13041-024-01146-x
Chronic corticosterone exposure causes anxiety- and depression-related behaviors with altered gut microbial and brain metabolomic profiles in adult male C57BL/6J mice.
Journal: Molecular brain
In common: mouse, 2 references

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.

Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.